Background: The reduction of the number of negative prostate biopsies in patients with elevated serum PSA represents a major challenge. Several angiogenetic biomarkers are involved in carcinogenesis and cancer progression. The aim of our preliminary study was to investigate if their serum levels might be related to prostate cancer detection. Patients and Methods: Angiopoietin 2, Follistatin, G-CSF, HGF, IL-8, Leptin, PDGF- BB, PECAM-1, VEGF, PTH were the selected biomarkers for our research. They were measured by BioPlex immunoassay. As a preliminary step, consecutive unselected patients undergoing prostate biopsy for palpable prostate nodule and/or elevated PSA levels were entered. A 12-core transrectal biopsy was planned. The serum levels...
OBJECTIVE: To investigate the association between serum prostate-specific antigen (PSA) concentratio...
<p>Purpose: to establish the nature of change of the maintenance of PSA and markers of angiogenesis ...
Globally, Prostate cancer (PCa) is the most frequently occurring non-cutaneous cancer, and is the se...
Background: The reduction of the number of negative prostate biopsies in patients with elevated seru...
To reduce the number of negative prostate biopsies in patients with elevated PSA serum levels repres...
Aim To investigate the relationship of serum prostate-specific antigen (PSA) levels with outcomes of...
Introduction/Aim: To reduce the number of negative prostate biopsies and to detect clinical signific...
Context: Prostate cancer (PCa) is the second most common type of cancer in men. Individualized risk ...
Background. Prostate cancer (PCa) is the first in terms of occurrence in Europe and second in Poland...
Background. To evaluate the diagnostic potential of [-2] proPSA (p2PSA), %p2PSA, Prostate Health Ind...
The current literature does not support the usefulness of clinical markers on predicting which patie...
In the U.S., the number of prostate biopsies increases annually. This is partly due to elevated pros...
Prostate cancer is the second leading cause of cancer death in men and there is an urgent clinical n...
Abstract Prostate-specific antigen (PSA) screening for prostate cancer (PCa) is limited by the lack ...
Background. To evaluate the diagnostic potential of [-2] proPSA (p2PSA), %p2PSA, Prostate Health Ind...
OBJECTIVE: To investigate the association between serum prostate-specific antigen (PSA) concentratio...
<p>Purpose: to establish the nature of change of the maintenance of PSA and markers of angiogenesis ...
Globally, Prostate cancer (PCa) is the most frequently occurring non-cutaneous cancer, and is the se...
Background: The reduction of the number of negative prostate biopsies in patients with elevated seru...
To reduce the number of negative prostate biopsies in patients with elevated PSA serum levels repres...
Aim To investigate the relationship of serum prostate-specific antigen (PSA) levels with outcomes of...
Introduction/Aim: To reduce the number of negative prostate biopsies and to detect clinical signific...
Context: Prostate cancer (PCa) is the second most common type of cancer in men. Individualized risk ...
Background. Prostate cancer (PCa) is the first in terms of occurrence in Europe and second in Poland...
Background. To evaluate the diagnostic potential of [-2] proPSA (p2PSA), %p2PSA, Prostate Health Ind...
The current literature does not support the usefulness of clinical markers on predicting which patie...
In the U.S., the number of prostate biopsies increases annually. This is partly due to elevated pros...
Prostate cancer is the second leading cause of cancer death in men and there is an urgent clinical n...
Abstract Prostate-specific antigen (PSA) screening for prostate cancer (PCa) is limited by the lack ...
Background. To evaluate the diagnostic potential of [-2] proPSA (p2PSA), %p2PSA, Prostate Health Ind...
OBJECTIVE: To investigate the association between serum prostate-specific antigen (PSA) concentratio...
<p>Purpose: to establish the nature of change of the maintenance of PSA and markers of angiogenesis ...
Globally, Prostate cancer (PCa) is the most frequently occurring non-cutaneous cancer, and is the se...